About
Small molecular weight enzyme inhibitors; imaging and drug delivery
Areas of Focus
Categories
DiagnosticsDrug Delivery & FormulationSeattle/Pacific Northwest
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
41
By Phase
PHASE1: 3
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT03822871Lead Sponsor
A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer
PHASE1Completed
17 participants
Started: Apr 1, 2019 · Completed: Feb 8, 2023
NCT03427476Lead Sponsor
CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma
PHASE1Completed
4 participants
Started: Jan 1, 2018 · Completed: Aug 31, 2018
NCT02916537Lead Sponsor
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057
PHASE1Completed
20 participants
Started: Sep 30, 2016 · Completed: Aug 28, 2017
Locations (1)
Headquarters
Woodinville, WA, United States
Map
Loading map...